These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 18199868)

  • 1. Clinical penetrance of hereditary hemochromatosis.
    Bacon BR; Britton RS
    N Engl J Med; 2008 Jan; 358(3):291-2. PubMed ID: 18199868
    [No Abstract]   [Full Text] [Related]  

  • 2. Iron-overload-related disease in HFE hereditary hemochromatosis.
    Allen KJ; Gurrin LC; Constantine CC; Osborne NJ; Delatycki MB; Nicoll AJ; McLaren CE; Bahlo M; Nisselle AE; Vulpe CD; Anderson GJ; Southey MC; Giles GG; English DR; Hopper JL; Olynyk JK; Powell LW; Gertig DM
    N Engl J Med; 2008 Jan; 358(3):221-30. PubMed ID: 18199861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical consequences of iron overload in hemochromatosis homozygotes.
    Ajioka RS; Kushner JP
    Blood; 2003 May; 101(9):3351-3; discussion 3354-8. PubMed ID: 12707221
    [No Abstract]   [Full Text] [Related]  

  • 4. Hemochromatosis and iron-overload screening in a racially diverse population.
    Adams PC; Reboussin DM; Barton JC; McLaren CE; Eckfeldt JH; McLaren GD; Dawkins FW; Acton RT; Harris EL; Gordeuk VR; Leiendecker-Foster C; Speechley M; Snively BM; Holup JL; Thomson E; Sholinsky P;
    N Engl J Med; 2005 Apr; 352(17):1769-78. PubMed ID: 15858186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Case report of a patient with non-alcoholic fatty liver disease, moderate iron overload who is homozygous for the S65C mutation in the HFE1 gene.
    Bernard PH; Ged C; Faivre E; Legac G; Bioulac-Sage P; Cassaigne A; de Verneuil H
    Eur J Med Genet; 2005; 48(2):195-8. PubMed ID: 16053912
    [No Abstract]   [Full Text] [Related]  

  • 6. Genetic predisposition to iron overload: prevalence and phenotypic expression of hemochromatosis-associated HFE-C282Y gene mutation.
    Distante S
    Scand J Clin Lab Invest; 2006; 66(2):83-100. PubMed ID: 16537242
    [No Abstract]   [Full Text] [Related]  

  • 7. Characteristics of HFE C282Y homozygotes younger than age 30 years.
    Barton JC; Felitti VJ; Lee P; Beutler E
    Acta Haematol; 2004; 112(4):219-21. PubMed ID: 15564736
    [No Abstract]   [Full Text] [Related]  

  • 8. Correlation between iron status and genetic hemochromatosis (codon C282Y) in a large German population.
    Wrede CE; Hutzler S; Bollheimer LC; Buettner R; Hellerbrand C; Schöelmerich J; Palitzsch KD
    Isr Med Assoc J; 2004 Jan; 6(1):30-3. PubMed ID: 14740507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Letter to the editor: regarding "Hemochromatosis genotypes and risk of iron overload-a meta-analysis".
    Castiella A; Zapata E; Zubiaurre L; de Juan MD; Otazua P
    Ann Epidemiol; 2011 Oct; 21(10):796. PubMed ID: 21605983
    [No Abstract]   [Full Text] [Related]  

  • 10. Natural history of hemochromatosis.
    Beutler E
    Mayo Clin Proc; 2004 Mar; 79(3):305-6. PubMed ID: 15008601
    [No Abstract]   [Full Text] [Related]  

  • 11. The relationship between iron overload and clinical characteristics in a Spanish cohort of 100 C282Y homozygous hemochromatosis patients.
    Altes A; Ruiz A; Martinez C; Esteve A; Vela MD; Remacha AF; Sarda P; Bach V; Baiget M
    Ann Hematol; 2007 Nov; 86(11):831-5. PubMed ID: 17639389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical penetrance of C282Y homozygous HFE hemochromatosis in a western Romanian population.
    Neghina AM; Anghel A; Sporea I; Popescu A
    J Gastrointestin Liver Dis; 2011 Mar; 20(1):100-1. PubMed ID: 21451811
    [No Abstract]   [Full Text] [Related]  

  • 13. Low clinical penetrance of homozygosity for HFE C282Y: implications for genetic testing?
    Födinger M; Sunder-Plassmann G
    Eur J Clin Invest; 2003 Sep; 33(9):737-9. PubMed ID: 12925029
    [No Abstract]   [Full Text] [Related]  

  • 14. Hereditary hemochromatosis and its elusive natural history.
    McDonnell SM; Parrish RG
    Arch Intern Med; 2003 Nov; 163(20):2421-3; author reply 2427. PubMed ID: 14609775
    [No Abstract]   [Full Text] [Related]  

  • 15. Coexistent hereditary hemochromatosis and alpha1-antitrypsin deficiency.
    Shen R; Frankel WL; Wen P
    Arch Pathol Lab Med; 2004 Apr; 128(4):491-2. PubMed ID: 15043477
    [No Abstract]   [Full Text] [Related]  

  • 16. HFE genotype in patients with hemochromatosis and other liver diseases.
    McLaren GD
    Ann Intern Med; 2000 Feb; 132(3):245; author reply 246. PubMed ID: 10651611
    [No Abstract]   [Full Text] [Related]  

  • 17. HFE genotype in patients with hemochromatosis and other liver diseases.
    Powell LW
    Ann Intern Med; 2000 Feb; 132(3):245-6. PubMed ID: 10651612
    [No Abstract]   [Full Text] [Related]  

  • 18. Revisiting hereditary hemochromatosis: current concepts and progress.
    Yen AW; Fancher TL; Bowlus CL
    Am J Med; 2006 May; 119(5):391-9. PubMed ID: 16651049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The biochemical and clinical penetrance of individuals diagnosed with genetic haemochromatosis by predictive genetic testing.
    Watkins S; Thorburn D; Joshi N; Neilson M; Joyce T; Spooner R; Cooke A; Mills PR; Morris AJ; Stanley AJ
    Eur J Gastroenterol Hepatol; 2008 May; 20(5):379-83. PubMed ID: 18403938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hemochromatosis, a public health problem].
    Aguilar Martinez P
    Soins; 2007 Jun; (716):34-5. PubMed ID: 17718029
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.